AXS Investments’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
AXS Investments's LLY Position: Q1 2026 in Review
AXS Investments reduced its Eli Lilly (LLY) stake by 22% in Q1 2026, selling an estimated $40.6K and leaving 141 shares worth $130K. The position accounts for 0.05% of the portfolio, ranked #130.
AXS Investments first reported a position in LLY in Q1 2021 and has held it in 19 quarters since. The position peaked at $1.6M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- AXS Investments held 141 shares of Eli Lilly worth $130K as of Q1 2026.
- AXS Investments sold 40 Eli Lilly shares in Q1 2026, an estimated $40.6K.
- Eli Lilly made up 0.05% of AXS Investments's portfolio in Q1 2026, its #130 holding.
- AXS Investments first reported a position in Eli Lilly in Q1 2021 and has held it in 19 quarters since.
- AXS Investments's Eli Lilly position peaked at $1.6M in Q2 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on AXS Investments's 13F filing for Q1 2026, filed 6 May 2026.